Lilly Bounces Into ‘Sell in May’ Territory Amid Pricing Pressure
Eli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
This comparison outlines 2024 tax treatment differences between dividends from ETFs and mutual funds for informed decisions.
24,763 articlesEli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
MercadoLibre reports a robust Q1 2026 with revenue rising sharply, even as margins compress. Analysts increasingly vi...
As investors parse Nano-X Imaging's Q4 2025 results, this guide breaks down the numbers, the business model, and what...
Five dormant Bitcoin wallets from 2014 woke up to burn 107 BTC, worth about $8.3 million at the time. The coordinated...
Investors cheered a decisive move higher as Okta unveiled AI-powered growth opportunities. The stock touched a new 52...
CrowdStrike shares declined about 9% after a fiscal Q1 beat that failed to meet loftier expectations, triggering a br...
Over the weekend, the odds rate hike passed surged, prompting a dramatic re-pricing of the Federal Reserve path. Here...
Broadcom posted a strong quarter, but AI guidance missed whispers and the stock sold off sharply, underscoring a new ...
Two AI pioneers sit on the public markets' doorstep with wall-high expectations. This guide breaks down which giant—a...
Markets brace for a potential rate move at the July FOMC meeting as JPMorgan Asset Management weighs in on Warsh-era ...
Palantir sits at a crossroads of defense data and biotech action. This article explores why palantir's bold biosecuri...
Coinbase stock faces a tough year, but cost reductions and a rebound in crypto activity could spark a meaningful rall...